CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins

Blood

Volumn 90, Issue 12, 1997, Pages 4947-4952

  Carroll, Martin ^b   Ohno Jones, Sayuri ^b   Tamura, Shu ^b   Buchdunger, Elisabeth ^b   Zimmermann, Jürg ^b   Lydon, Nicholas B ^b   Gilliland, D Gary ^b   Druker, Brian J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPYRIDINE DERIVATIVE; BCR ABL PROTEIN; DNA BINDING PROTEIN; HYBRID PROTEIN; IMATINIB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TRANSCRIPTION FACTOR;

ACUTE LYMPHOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL GROWTH; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031454003     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.12.4947.4947_4947_4952     Document Type: Article

References (28)

1. Ben-Neriah Y, Daley GQ, Mes-Masson A-M, Witte ON, Baltimore D: The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science 233:212, 1986
2. Shtivelman E, Lifshitz B, Gale RP, Canaani E: Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315:550, 1985
3. Hermans A, Heisterkamp N, von Lindern M, van Baal S, Meijer D, van der Plas D, Wiedemann LM, Groffen J, Bootsma D, Grosveld G: Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 51:33, 1987
4. Clark SS, McLaughlin J, Timmons M, Pendergast AM, Ben-Neriah Y, Dow LW, Crist W, Rovera G, Smith SD, Witte ON: Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL). Science 239:775, 1988
5. Kantarjian HM, Deisseroth AB, Kurzrock R, Estrov Z, Talpaz M: Chronic myelogenous leukemia: A concise update. Blood 82:691, 1993
6. Goldman JM: Management of chronic myeloid leukaemia. Blood Rev 8:21, 1994
7. Lugo TG, Pendergast AM, Muller AJ, Witte ON: Tyrosine kinase activity and transformation potency of bcr-abl oneogene products. Science 247:1079, 1990
8. Oda T, Tamura S, Matsuguchi T, Griffin JD, Druker BJ: The SH2 domain of Abl is not required for factor independent growth induced by Bcr-Abl in a murine myeloid cell line. Leukemia 9:295, 1995
9. McWhirter JR, Wang JYJ: Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol Cell Biol 11:1553, 1991
10. McWhirter JR, Galasso DL, Wang JYJ: A coiled-coiled oligomerization domain of Bcr is essential for the transforming function of Bcr-ABl oncoproteins. Mol Cell Biol 13:7587, 1993
11. Muller AJ, Young JC, Pendergast AM, Pondel M, Landau NR, Littman DR, Witte ON: BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oneogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol 11:1785, 1991
12. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM: The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 55:34, 1995
13. Golub TR, McLean T, Stegmaier K, Carroll M, Tomasson M, Gilliland DG: The TEL gene and human leukemia. Biochimica et Biophysica Acta 1288:M7, 1996
14. Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG: Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 16:4107, 1996
15. Okuda K, Golub TR, Gilliland DG, Griffin JD: p210BCR/ ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cells. Oncogene 13:1147, 1996
16. Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307, 1994
17. Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG: The Tel platelet-derived growth factor beta receptor (PDGF-beta-R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF-beta-R kinase-dependent signaling pathways. Proc Natl Acad Sci USA 93:14845, 1996
18. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB: Effects of a selective inhibitor of the ABL tyrosine kinase on the growth of BCR-ABL positive cells. Nature Med 2:361, 1996
19. Buchdunger E, Zimmermann J, Mett H, Meyer T, Müller M, Druker BJ, Lydon NB: Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 56:100, 1996
20. Kanakura Y, Druker B, Cannistra SA, Furukawa Y, Torimoto Y, Griffin JD: Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves a common set of cytoplasmic proteins. Blood 76:706, 1990
21. Greenberger JS, Sakakeeny MA, Humphries RK, Eaves CJ, Eckner RJ: Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 80:2391, 1983
22. Avanzi GC, Lista P, Giovinazzo B, Miniero R, Saglio G, Benetton G, Coda R, Cattoretti G, Pegoraro L: Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br J Haematol 69:359, 1988
23. Matsuguchi T, Salgia R, Hallek M, Eder M, Druker B, Ernst T, Griffin JD: SHC phosphorylation in myeloid cells is regulated by GM-CSF, IL-3, and steel factor and is constitutively increased by p210BCR-ABL. J Biol Chem 269:5016, 1994
24. Matulonis U, Salgia R, Okuda K, Druker B, Griffin JD: IL-3 and p210BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Exp Hematol 21:1460, 1993
25. Lozzio CB, Lozzio BB: Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45:321, 1975
26. Mossman T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55, 1983
27. Druker B, Okuda K, Matulonis U, Salgia R, Roberts T, Griffin JD: Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines. Blood 79:2215, 1992
28. Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T, Ihle JN: Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci USA 90:8429, 1993